NCT05152641View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

July 31, 2024

Conditions
Acute Posthemorrhagic Anemia
Interventions
DRUG

BGE-117, 4mg

BGE-117, 4mg Capsules

DIETARY_SUPPLEMENT

Ferrous Sulfate

Ferrous Sulfate, 325mg Tablets

OTHER

Matching Placebo

Matching Placebo to BGE-117 Capsules

DRUG

BGE-117, 12mg

BGE-117, 12mg Capsules

Trial Locations (1)

2250

Renal Research, Gosford

Sponsors

Lead Sponsor

BioAge Labs, Inc.
All Listed Sponsors
lead

BioAge Labs, Inc.

INDUSTRY